In the BioHarmony Drug Report Database

"Preview" Icon

Mesalamine

Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa (mesalamine) is a small molecule pharmaceutical. Mesalamine was first approved as Apriso on 1987-12-24. It is used to treat proctitis, sigmoid diseases, and ulcerative colitis in the USA. It is known to target peroxisome proliferator-activated receptor gamma. Pentasa’s patents are valid until 2030-05-01 (FDA).

 

Trade Name

 

Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa
 

Common Name

 

mesalamine
 

ChEMBL ID

 

CHEMBL704
 

Indication

 

proctitis, sigmoid diseases, ulcerative colitis
 

Drug Class

 

Anti-inflammatory agents (salicylic acid derivatives)

Image (chem structure or protein)

Mesalamine structure rendering